Cell Banking
يعرف أيضا باسم: الحفظ بالتبريد للخلايا, بنك الخلايا الجذعية, بنك دم الحبل السري, تخزين الخلايا الجذعية, حفظ الخلايا الذاتية, سيل بانكينج, SVF
Cell banking is a service that isolates and cryopreserves a person's own cells, such as adipose SVF, for possible future use.
제대혈 줄기세포는 성체줄기세포인가요? 어디에 쓰이나요?
제대혈 줄기세포는 출산 때 탯줄과 태반에 남은 혈액에서 얻는 줄기세포입니다. 배아줄기세포가 아니라는 점에서 넓게는 성체(체성)줄기세포에 넣고, 출생 시점에 얻는다는 뜻에서 주산기 줄기세포로 따로 부르기도 합니다. 주성분은 혈액을 만드는 조혈모세포이며, 미국 FDA가 허가한 용도도 백혈병 등 조혈계 질환의 이식에 한정됩니다.
حقائق أساسية
| المحمول | القيمة | المصدر |
|---|---|---|
| Private vs public banking | Private banks store cord blood for the child donor or first- or second-degree relatives. Public banks store donated units for unrelated patients.حتى تاريخ 23 مارس 2018 | [3]governmentCord Blood Banking - Information for ConsumersU.S. Food and Drug Administration |
| US regulation of private cord blood banks | Must register with the FDA and follow donor screening, infectious disease testing and current good tissue practice rules. Cord blood for personal or close-relative use does not need approval before use.حتى تاريخ 23 مارس 2018 | [3]governmentCord Blood Banking - Information for ConsumersU.S. Food and Drug Administration |
| Meaning of FDA registration | Registration only confirms that the facility notified the FDA of its operations. It is not an endorsement.حتى تاريخ 23 مارس 2018 | [3]governmentCord Blood Banking - Information for ConsumersU.S. Food and Drug Administration |
| FDA-approved stem cell products | Only cord blood-derived blood-forming stem cells for disorders of blood production. Adipose-derived and other products are not approved for orthopedic, neurological, cardiovascular or other conditions.حتى تاريخ 9 أبريل 2024 | [4]governmentConsumer Alert on Regenerative Medicine Products Including Stem Cells and ExosomesU.S. Food and Drug Administration |
| Korea: family cord blood bank licence | Under the Act on Cord Blood Management and Research, a family cord blood bank needs a licence from the Minister of Health and Welfare and must meet facility, equipment, staffing and quality-management requirements.حتى تاريخ 1 يوليو 2011 | [5]other제대혈 관리 및 연구에 관한 법률 (Act on Cord Blood Management and Research, Law No. 10130)Wikisource (Korean) – statutory text |
| Korea: cell processing facility approval | Cell processing requires MFDS approval as an advanced regenerative medicine cell processing facility, and the licence must be renewed every 3 years (Advanced Regenerative Bio Act, Art. 15).حتى تاريخ 28 أغسطس 2020 | [6]other첨단재생의료 및 첨단바이오의약품 안전 및 지원에 관한 법률 제15조(첨단재생의료세포처리시설)CaseNote (법령 원문) |
| Korea 2025 amendment | Took effect 2025-02-21. It added a treatment track that needs committee approval of each plan. Institutions that supply patient-derived cells after only minimal manipulation (isolation, washing, freezing, thawing) are treated as licensed.حتى تاريخ 21 فبراير 2025 | [7]industry첨단재생의료 및 첨단바이오의약품 안전 및 지원에 관한 법률의 개정 및 시행과 그 시사점법무법인(유) 세종 |
| Evidence on cryopreserved SVF | A systematic review (studies 2008–2025) found post-thaw SVF viability broadly comparable to fresh tissue. It said standardized protocols and functional potency assays are still needed.حتى تاريخ 1 أغسطس 2026 | [8]journalEffects of Cryopreservation on Stromal Vascular Fraction Viability in Human Adipose Tissue: Insights from a Systematic Review (Farhana S et al., Tissue Eng Regen Med, DOI 10.1007/s13770-026-00833-1)Europe PMC / Tissue Engineering and Regenerative Medicine (Springer Nature) |
| Factors affecting SVF quality | Longer freezing periods and longer enzymatic digestion reduced viability, and storage temperature itself had little effect. Short-term storage (<1 month) with cryoprotectants such as DMSO or trehalose was associated with the best preservation.حتى تاريخ 1 أغسطس 2026 | [8]journalEffects of Cryopreservation on Stromal Vascular Fraction Viability in Human Adipose Tissue: Insights from a Systematic Review (Farhana S et al., Tissue Eng Regen Med, DOI 10.1007/s13770-026-00833-1)Europe PMC / Tissue Engineering and Regenerative Medicine (Springer Nature) |
| Public cord blood collections not stored | 85–90% of collected samples are not stored, because public banks prioritize larger units (as reported in a review) %حتى تاريخ 7 أكتوبر 2024 | [9]journalCord blood banking: Balancing hype and hope in stem cell therapyEuropean Journal of Midwifery (via PubMed Central) |
| Storage temperature | Liquid nitrogen, about −196 °C | [1]governmentNCI Dictionary of Cancer Terms: cryopreservationNational Cancer Institute (NCI) |
| What to check | Approved future use, viability testing after thaw, facility licensing, contract terms and fees | [2]organizationAbout Stem Cells — patient resourceInternational Society for Stem Cell Research |
نظرة عامة
Cell banking (셀뱅킹) is a service that cryopreserves a person's own cells or tissue, such as umbilical cord blood or adipose-derived stromal vascular fraction (SVF), for possible later use. Private (family) banks store cells for the donor or relatives for a fee, while public banks hold donated cord blood for unrelated patients. In the US, private cord blood banks must register with the FDA and follow donor-testing and tissue-practice rules. Registration does not mean the FDA endorses the bank. The only FDA-approved stem cell products are cord blood-derived blood-forming cells for blood disorders. In Korea, family cord blood banks need a health ministry licence, and cell processing needs MFDS approval. Studies report that the quality of frozen SVF varies with processing and storage time. Readers should check the bank's licences and which regulated uses actually exist.
مزودون موثقون
القوائم المدفوعة موسومة بوضوح. التحقق مستقل عن الدفع.SC301의원
SC301의원 (SC301 Clinic) is a plastic surgery clinic in Gangnam, Seoul, South Korea whose official site presents SVF (stromal vascular fraction) fat grafting for the breast and face, liposuction, lifting and cell banking as its main services.
عرض المزودالمراجع
نسبة المصادر المستقلة 89% (8/9)- المستوى A · governmentNCI Dictionary of Cancer Terms: cryopreservation — National Cancer Institute (NCI) · تاريخ الاطلاع 12 نوفمبر 2026 · صفحة الدليل
- المستوى C · organizationAbout Stem Cells — patient resource — International Society for Stem Cell Research · تاريخ الاطلاع 12 نوفمبر 2026 · صفحة الدليل
- المستوى A · governmentCord Blood Banking - Information for Consumers — U.S. Food and Drug Administration · تاريخ الاطلاع 10 نوفمبر 2026 · صفحة الدليل
- المستوى A · governmentConsumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes — U.S. Food and Drug Administration · تاريخ الاطلاع 12 نوفمبر 2026 · صفحة الدليل
- المستوى E · other제대혈 관리 및 연구에 관한 법률 (Act on Cord Blood Management and Research, Law No. 10130) — Wikisource (Korean) – statutory text · تاريخ الاطلاع 10 نوفمبر 2026 · صفحة الدليل
- المستوى C · other첨단재생의료 및 첨단바이오의약품 안전 및 지원에 관한 법률 제15조(첨단재생의료세포처리시설) — CaseNote (법령 원문) · تاريخ الاطلاع 10 نوفمبر 2026 · صفحة الدليل
- المستوى D · industry첨단재생의료 및 첨단바이오의약품 안전 및 지원에 관한 법률의 개정 및 시행과 그 시사점 — 법무법인(유) 세종 · تاريخ الاطلاع 10 نوفمبر 2026 · صفحة الدليل
- المستوى B · journalEffects of Cryopreservation on Stromal Vascular Fraction Viability in Human Adipose Tissue: Insights from a Systematic Review (Farhana S et al., Tissue Eng Regen Med, DOI 10.1007/s13770-026-00833-1) — Europe PMC / Tissue Engineering and Regenerative Medicine (Springer Nature) · تاريخ الاطلاع 12 نوفمبر 2026 · صفحة الدليل
- المستوى B · journalCord blood banking: Balancing hype and hope in stem cell therapy — European Journal of Midwifery (via PubMed Central) · تاريخ الاطلاع 11 نوفمبر 2026 · صفحة الدليل